Analysis of the T cell response to tumor and viral peptide antigens by an IFNγ-ELISPOT assay

International Journal of Cancer

Volumn 71, Issue 6, 1997, Pages 932-936

  Scheibenbogen, Carmen ^a,c   Lee, Kang Hun ^a   Stevanovic, Stefan ^b   Witzens, Mathias ^a   Willhauck, Martina ^a   Waldmann, Volker ^a   Naeher, Helmut ^a   Rammensee, Hans Georg ^b   Keilholz, Ulrich ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Medizinische Klinik und Poliklinik V   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; HLA A1 ANTIGEN; HLA A2 ANTIGEN; INTERLEUKIN 2; MELANOMA ANTIGEN; VIRUS PROTEIN;

ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HLA-A1 ANTIGEN; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; MELANOMA; T-LYMPHOCYTES;

EID: 0030916776     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970611)71:6<932::AID-IJC3>3.0.CO;2-Z     Document Type: Article

References (32)

1. BAROUCH, D., FRIEDE, T., STEVANOVIC, S., TUSSEY, L., SMITH, K., ROWLAND-JONES, S., BRAUD, V., MCMICHAEL, A. and RAMMENSEE, H.-G., HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. exp. Med., 182, 1847-1856 (1995).
2. BEDNAREK, M.A., SAUMA, S.Y., GAMMON, M.C., PORTER, G., TAMHANKAR, S., WILLIAMSON, A.R. and ZWEERINK, H., The minimum peptide epitope from the influenza virus matrix protein. J. Immunol., 147, 4047-4053 (1991).
3. BOON, T., GAJEWSKI, T.F. and COULIE, P., From defined tumor antigens to effective immunization? Immunol. Today, 16, 334-336 (1995).
4. + CTL. J. exp. Med., 181, 363-368 (1995).
5. CERROTINI, J.C. and BRUNNER, K.T., Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv. Immunol., 18, 67-132 (1974).
6. COULIE, P.G., BRICHARD, V., VAN PEL, A., WOELFEL, T., SCHNEIDER, J., TRAVERSARI, C., MATTEI, S., DE PLAEN, E., LURQUIN, C., SZIKORA, J.P., RENAULD, J.C. and BOON, T., A new gene coding for a differentiation antigen recognized by autologous cytoloytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-42 (1994).
7. Cox, A.L., SKIPPER, J., CHEN, Y., HENDERSEN, R.A., DARROW, T.L., SHABANOWITZ, J., ENGELHARD, V.H., HUNT, D.F. and SLINGLUFF, C.L., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719 (1994).
8. CZERKINSKY, C.C., ANDERSSON, G., EKRE, H.P., NILSSON, L.A., KLARESKOG, L. and OUCHTERLONY, O., Reverse ELISPOT assay for clonal analysis of cytokine production. Enumeration of gamma-interferon secreting cells. J. Immunol. Methods, 110, 29-36 (1988).
9. DI BRINO, M., TSUCHIDA, T., TURNER, R.V., PARKER, K.C., COLIGAN, J.E. and BIDDISON, W.E., HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J. Immunol., 151, 5930-5935 (1993).
10. FALK, K., RÖTZSCHKE, O., STEVANOVIC, S., JUNG, G. and RAMMENSEE, H.-G., Allele specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.), 351, 290-296 (1991).
11. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DH PLAEN, E., LETHE,́ B., BRASSEUR, F. and BOON, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytoloytic T lymphocytes. J. exp. Med., 179, 921-930 (1994).
12. HECHT, T.T., LONGO, D.L. and MATIS, L.A., The relationship between immune interferon production and proliferation in antigen-specific MHC-restricted T cell lines and clones. J. Immunol., 131, 1049-1055 (1983).
13. +T lymphocytes secreting TNFα in response to HLA-A2.1-binding melanoma and viral peptide antigens. J. Immunol. Methods, 191, 131-143 (1996).
14. HOM, S., SCHWARTZENTRUBER, D.J., ROSENBERG, S.A. and TOPALIAN, S.L., Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens. J. Immunother. 13, 18-30 (1993).
15. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., SAKAGUCHI, K., APELLA, E., YANELLI, J.R., ADEMA, G.J., MIKI, T. and ROSENBERG, S.A., Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. nat. Acad. Sci. (Wash.), 91, 6458-6462 (1994a).
16. KAWAKAMI, Y., ELIYAHU, S., SAKAGUCHI, K., ROBBINS, P.F., RIVOLTINI, L., YANELLI, J.R., APELLA, E. and ROSHNBERG, S.A., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. exp. Med., 180, 347 (1994b).
17. KEILHOLZ, U., GOEY, S.H., PUNT, C.J.A., PROEBSTLE, T., SALZMANN, R., SCHEIBENBOGEN, C., SCHADENDORF, D., LIENARD, D., HANTICH, B., GEUEKE, A.-M. and EGGERMONT, A.M.M., IFNα/IL-2 with or without cisplatinum in metastatic melanoma: a randomized trial of the EORTC melanoma cooperative group. J. clin. Oncol., 15, 436 (1996).
18. KEILHOZ, U., SCHEIBENBOGEN, C. TILGEN, W., BERGMANN, L., WEIDMANN, E., RICHTER, M., MITROU, P.S. and HUNSTEIN, W., IFNα and IL-2 in the treatment of malignant melanoma: a comparison of two phase II trials. Cancer, 72, 607-614 (1993).
19. LOFTUS, D., CASTELLI, C., CLAY, T.M., SQUARCINA, P., MARINCOLA, F.M., NISHIMURA, M.I., ROSENBERG, S.A., PARMIANI, G., APPELLA, E. and RIVOLTINI, L., Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1 (27-35). J. exp. Med., 184, 647-657 (1996).
20. MARINCOLA, P.M., RIVOLTINI, L., SALGALLER, M.L., PLAYER, M. and ROSENBERG, S.A., Differential anti-MART-1/Melan-A CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors; evidence for in vivo priming by tumor cells. J. Immunother., 19, 192-205 (1996).
21. MAYER, S., SCHEIBENBOGEN, C., LEE, K.H., KEILHOLZ, W., STEVANOVIC, S., RAMMENSEE, H.G. and KEILHOLZ, U., A sensitive proliferation assay to determine a specific T-cell response against an HLA-A2.1-binding peptide. J. Immunol. Methods. 197, 131-137 (1996).
22. MOEHLER, T., WILLHAUCK, M., SCHEIBENBOGEN, C., PAWLITA, M., BROS- SART, P., HUNSTEIN, W. and KEILHOLZ, U., Restriction of T cell receptor Vβ repertoire in melanoma metastasis and response to immunotherapy. Melanoma Res., 5, 129-132 (1995).
23. PROEBSTLE, T., SCHEIBENBOGEN, C., STERRY, W. AND KEILHOLZ, U., A phase II study of DTIC, CDDP, IFNα and IL-2 in poor-risk melanoma patients. Europ. J. Cancer, 32A, 1530-1533 (1996).
24. RAMMENSEE, H.G., FRIEDE, T. and STEFANOVIC, S., MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228 (1995).
25. RIVOLTINI, L., KAWAKAMI Y., SAKAGUCHI, K., SOUTHWOOD, S., SETTE, A., ROBBINS, P.F., MARINCOLA, P.M., SALGALLER, M.L., YANELLI J.R., APELLA, E. and ROSENBERG, S.A., Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154, 2257-2265 (1995).
26. + T-lymphocytes specific for HLA class I binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients. Clin. Cancer Res., 3, 221-226 (1997).
27. TASWELL, C., Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol., 126, 614-619 (1981).
28. TRAVERSARI, C., VAN DER BRUGGEN, P., LUESCHER, I., et al., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by CTL directed against tumor antigen MZ2-E. J. exp. Med., 176, 1453-1459 (1992).
29. TSOMIDES, T.J., WALKER, B.D. and EISEN, H.N., An optimal viral peptide recognized by CD8+ T-cells binds very tightly to the restricting class I MHC protein on intact cells but not to the purified class I protein. Proc. nat. Acad. Sci. (Wash.), 88, 11276-11280 (1991).
30. WILLHAUCK, M., MÖHLER, T., SCHEIBENBOGEN, C., PAWLITA, M., BROSSART, P., SCHMIER, J. and KEILHOLZ, U., T cell receptor β variable region diversity in melanoma metastases after IL-2-based immunotherapy. Clin. Cancer Res., 2, 767-772 (1996).
31. WOELFEL, T., VAN PEL, A., BRICHARD, V., SCHNEIDER, J., SELIGER, B., MEYER ZUM BÜSCHENFELDE, K.H. and BOON, T., Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Europ. J. Immunol., 24, 759-764 (1994).
32. ZIER, K., GANSBACHER, B. and SALVADORI, S., Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol. Today, 17, 39-45 (1996).